Video

VIDEO: PDT tops blue-light therapy for actinic keratosis


 

EXPERT ANALYSIS FROM SDEF HAWAII DERMATOLOGY SEMINAR

KAUAI, HAWAII – Using photodynamic therapy in place of blue-light therapy to reverse sun damage such as actinic keratosis is less expensive and associated with fewer adverse events such as pain, according to Dr. Christopher Zachary.

Dr. Zachary, chair of dermatology at the University of California, Irvine, shared his perspectives in a video on the advantages of photodynamic therapy over other field treatments, particularly in an era of changing health care reimbursements.

He spoke at the Hawaii Dermatology Seminar sponsored by Global Academy for Medical Education/Skin Disease Education Foundation. SDEF and this news organization are owned by the same parent company.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

MEK inhibitors can induce skin eruptions with distinctive duskiness
MDedge Dermatology
Handheld device illuminates possible routes of melanoma metastases
MDedge Dermatology
Teledermoscopy referrals surpass paper for managing skin cancer patients
MDedge Dermatology
Patient-led teledermoscopy appears feasible and effective
MDedge Dermatology
Xerosis is significant risk during targeted anticancer treatments
MDedge Dermatology
Overall survival plateaus at 3 years for ipilimumab-treated melanoma patients
MDedge Dermatology
Melanoma incidence highest in Oregon, lowest in Texas in 2015
MDedge Dermatology
Photographic AK counting isn’t ready for prime time
MDedge Dermatology
Laser plus PDT improves AK clearance in organ transplant recipients
MDedge Dermatology
Laser-enhanced 5-FU scores with squamous cell, basal cell patients
MDedge Dermatology